01.12.2021
Prevent & Delay
$18,802,739.00
92 months
The GPPAD-04 Study: Supplementation with B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)
Funding supports a randomized, placebo-controlled primary prevention clinical trial for type 1 diabetes.